Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13546
Country/Region: Kenya
Year: 2015
Main Partner: Henry M. Jackson Foundation for the Advancement of Military Medicine
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $2,875,556 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $395,237
Care: Orphans and Vulnerable Children (HKID) $215,117
Care: TB/HIV (HVTB) $134,694
Care: Pediatric Care and Support (PDCS) $77,651
Strategic Information (HVSI) $850,000
Prevention: HIV Testing and Counseling (HVCT) $125,811
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $158,644
Treatment: Adult Treatment (HTXS) $917,840
Treatment: Pediatric Treatment (PDTX) $562
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Age/sex: 1-4 Female 2016 155
CARE_CURR_DSD Age/sex: 1-4 Male 2016 158
CARE_CURR_DSD Age/sex: 10-14 Female 2016 214
CARE_CURR_DSD Age/sex: 10-14 Male 2016 214
CARE_CURR_DSD Age/sex: 15-19 Female 2016 107
CARE_CURR_DSD Age/sex: 15-19 Male 2016 68
CARE_CURR_DSD Age/sex: 20-24 Female 2016 447
CARE_CURR_DSD Age/sex: 20-24 Male 2016 126
CARE_CURR_DSD Age/sex: 25-49 Female 2016 3,818
CARE_CURR_DSD Age/sex: 25-49 Male 2016 1,901
CARE_CURR_DSD Age/sex: 5-9 Female 2016 281
CARE_CURR_DSD Age/sex: 5-9 Male 2016 272
CARE_CURR_DSD Age/sex: 50+ Female 2016 733
CARE_CURR_DSD Age/sex: 50+ Male 2016 656
CARE_CURR_DSD Age/sex: <1 Female 2016 22
CARE_CURR_DSD Age/sex: <1 Male 2016 23
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 4,393
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,365
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 552
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 550
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,275
CARE_CURR_DSD Sum of Age/Sex disaggregates 2016 9,195
CARE_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 7,860
CARE_NEW_DSD Age/sex: 1-4 Female 2016 38
CARE_NEW_DSD Age/sex: 1-4 Male 2016 38
CARE_NEW_DSD Age/sex: 10-14 Female 2016 53
CARE_NEW_DSD Age/sex: 10-14 Male 2016 53
CARE_NEW_DSD Age/sex: 15-19 Female 2016 26
CARE_NEW_DSD Age/sex: 15-19 Male 2016 17
CARE_NEW_DSD Age/sex: 20-24 Female 2016 102
CARE_NEW_DSD Age/sex: 20-24 Male 2016 28
CARE_NEW_DSD Age/sex: 25-49 Female 2016 883
CARE_NEW_DSD Age/sex: 25-49 Male 2016 434
CARE_NEW_DSD Age/sex: 5-9 Female 2016 71
CARE_NEW_DSD Age/sex: 5-9 Male 2016 68
CARE_NEW_DSD Age/sex: 50+ Female 2016 169
CARE_NEW_DSD Age/sex: 50+ Male 2016 152
CARE_NEW_DSD Age/sex: <1 Female 2016 7
CARE_NEW_DSD Age/sex: <1 Male 2016 7
CARE_NEW_DSD Aggregated Age/sex: 15+ Female 2016 790
CARE_NEW_DSD Aggregated Age/sex: 15+ Male 2016 425
CARE_NEW_DSD Aggregated Age/sex: <15 Female 2016 83
CARE_NEW_DSD Aggregated Age/sex: <15 Male 2016 80
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,149
CARE_NEW_DSD Sum of Age/sex disaggregates 2016 2,146
CARE_NEW_DSD Sum of Aggregated Age/sex disaggregates 2016 1,378
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 11,663
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 11,660
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 4,158
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 4,155
HTC_TST_DSD By Test Result: Negative 2016 34,486
HTC_TST_DSD By Test Result: Positive 2016 1,883
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 41,704
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 23,323
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 8,313
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 31,636
HTC_TST_DSD Sum of Test Result disaggregates 2016 36,369
OVC_ACC_DSD Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 4,100
OVC_SERV_DSD Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 5,079
PMTCT_ARV_DSD Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 809
PMTCT_ARV_DSD Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 763
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 55
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 597
PMTCT_ARV_DSD Sum of New and Current disaggregates 2016 652
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2016 90
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 693
PMTCT_EID_DSD Sum of Infant Age disaggregates 2016 90
PMTCT_STAT_DSD By: Known positives at entry 2016 80
PMTCT_STAT_DSD By: Number of new positives identified 2016 811
PMTCT_STAT_DSD Number of new ANC and L&D clients 2016 3,071
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 3,071
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2016 891
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 162
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 162
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,275
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 5,927
TX_CURR_DSD Age/Sex: 1-4 Female 2016 164
TX_CURR_DSD Age/Sex: 1-4 Male 2016 168
TX_CURR_DSD Age/Sex: 5-14 Female 2016 532
TX_CURR_DSD Age/Sex: 5-14 Male 2016 522
TX_CURR_DSD Age/Sex: <1 Female 2016 25
TX_CURR_DSD Age/Sex: <1 Male 2016 26
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2016 4,080
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2016 2,199
TX_CURR_DSD Aggregated Age/Sex: <1 Female 2016 17
TX_CURR_DSD Aggregated Age/Sex: <1 Male 2016 18
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 9,141
TX_CURR_DSD Sum of age/sex disaggregates 2016 9,140
TX_CURR_DSD Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 1,001
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2016 6,279
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 6,279
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2016 915
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2016 493
TX_NEW_DSD Aggregated Grouping by Age/Sex: <1 Female 2016 5
TX_NEW_DSD Aggregated Grouping by Age: <1 Male 2016 5
TX_NEW_DSD By Age/Sex: 1-4 Female 2016 41
TX_NEW_DSD By Age/Sex: 1-4 Male 2016 41
TX_NEW_DSD By Age/Sex: 10-14 Female 2016 54
TX_NEW_DSD By Age/Sex: 10-14 Male 2016 53
TX_NEW_DSD By Age/Sex: 15-19 Female 2016 26
TX_NEW_DSD By Age/Sex: 15-19 Male 2016 18
TX_NEW_DSD By Age/Sex: 20-24 Female 2016 105
TX_NEW_DSD By Age/Sex: 20-24 Male 2016 33
TX_NEW_DSD By Age/Sex: 25-49 Female 2016 902
TX_NEW_DSD By Age/Sex: 25-49 Male 2016 475
TX_NEW_DSD By Age/Sex: 5-9 Female 2016 71
TX_NEW_DSD By Age/Sex: 5-9 Male 2016 69
TX_NEW_DSD By Age/Sex: 50+ Female 2016 172
TX_NEW_DSD By Age/Sex: 50+ Male 2016 157
TX_NEW_DSD By Age/Sex: <1 Female 2016 7
TX_NEW_DSD By Age/Sex: <1 Male 2016 7
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 2,231
TX_NEW_DSD Sum of Age/Sex disaggregates 2016 2,231
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2016 1,408
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 6,203
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 6,203
Cross Cutting Budget Categories and Known Amounts Total: $120,000
Food and Nutrition: Policy, Tools, and Service Delivery $50,000
Food and Nutrition: Commodities $50,000
Key Populations: FSW $15,000
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Monitoring and evaluation of SW programs
Gender: Gender Equality $5,000
Equity in HIV prevention, care, treatment and support
Implementation